Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Merger to Form Programmable Nano-Medicines Company

Molecule model in an open hand

A life science venture investor is merging two of its biotechnology portfolio companies to form a single developer of nanoscale medications with programmable properties. . . . → Read More: Merger to Form Programmable Nano-Medicines Company

Start-Up Adapts Crispr for Molecular Detection, Raises $40M

Crispr graphic

A new company is underway that says it adapts the gene editing technique Crispr to make detecting nucleic acid targets like DNA or RNA faster and simpler. . . . → Read More: Start-Up Adapts Crispr for Molecular Detection, Raises $40M

High-Speed Biologic Injection Device Shown Feasible

Racing motorcycle

A developer of an auto-injection technology says its device can deliver a biologic drug under the skin in a fraction of the time of conventional syringes. . . . → Read More: High-Speed Biologic Injection Device Shown Feasible

Longevity Science Group Spins-Off Biotech Start-Up

Naked mole rat on black background

An organization funding research on extending the human life span by preventing age-related diseases is founding its first biotechnology company. . . . → Read More: Longevity Science Group Spins-Off Biotech Start-Up

Neuro Disease Biotech Gains $61M in Early Funds

Brain cell networks

A developer of treatments for Alzheimer’s disease that seeks to improve the condition of the brain’s support cells is raising £48 million ($US 61 million) in its first venture round. . . . → Read More: Neuro Disease Biotech Gains $61M in Early Funds

NIH Funds Antibody Discovery for Difficult Protein Targets

Chicken on a wooden floor

A biotechnology company is receiving NIH support for discovering antibodies that address the vast majority of proteins coded by the human genome, passed-up so far by drug makers. . . . → Read More: NIH Funds Antibody Discovery for Difficult Protein Targets

Vaccine Shown to Protect Against Multiple Hospital Pathogens

MRSA bacteria

Research with lab mice shows an experimental vaccine stimulates the body’s basic immune system to protect against a range of pathogens associated with hospital infections. . . . → Read More: Vaccine Shown to Protect Against Multiple Hospital Pathogens

Biomanufacturing Company Gains $9.5M in Early Funds

A company offering a biomanufacturing process it says is more efficient and scalable than conventional bio-production methods is raising $9.5 million in its first venture round. . . . → Read More: Biomanufacturing Company Gains $9.5M in Early Funds

Biotech, Univ. Labs Test Psychoactive Drug as PTSD Therapy

Brain activity graphic

A developer of treatments with psychedelic compounds for brain disorders is partnering with a lab at Yale University to assess methylone as a PTSD therapy. . . . → Read More: Biotech, Univ. Labs Test Psychoactive Drug as PTSD Therapy

Biosensor Developed to Detect Explosives, Land Mines

Land mine detection team, Tajikistan 2014

Researchers from a university biochemistry lab and company developing synthetic enzymes designed techniques using engineered bacteria to detect buried land mines at longer distances. . . . → Read More: Biosensor Developed to Detect Explosives, Land Mines